Application 021064

Type
NDA
Sponsor
LANTHEUS MEDCL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEFINITYPERFLUTRENINJECTABLE;INTRAVENOUS6.52MG/MLYesYes
002DEFINITY RTPERFLUTRENINJECTABLE;INTRAVENOUS6.52MG/MLYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
11994-011DefinityperflutrenLantheus Medical Imaging, Inc.NDACurrent
11994-011DefinityperflutrenLantheus Medical Imaging, Inc.NDACurrent
11994-011DefinityperflutrenLantheus Medical Imaging, Inc.NDACurrent
11994-011DefinityperflutrenLantheus Medical Imaging, Inc.NDACurrent
11994-011DefinityperflutrenLantheus Medical Imaging, Inc.NDACurrent
11994-017DEFINITY RTperflutrenLantheus Medical Imaging, Inc.NDACurrent
11994-017DEFINITY RTperflutrenLantheus Medical Imaging, Inc.NDACurrent
11994-017DEFINITY RTperflutrenLantheus Medical Imaging, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77703SUPPL 2024-03-04
77694SUPPL 2024-03-04
74448SUPPL 2023-06-06
74434SUPPL 2023-06-06
67030SUPPL2021-04-13
67029SUPPL2021-04-13
67020SUPPL2021-04-12
67019SUPPL2021-04-12
66317SUPPL2021-02-22
65282SUPPL2020-11-19
65263SUPPL2020-11-18
64170SUPPL2020-08-03
64156SUPPL2020-07-31
57145SUPPL2019-01-09
56856SUPPL2018-12-20
46939SUPPL2017-01-24
46938SUPPL2017-01-24
26610SUPPL2015-08-20
14267SUPPL2015-08-19
44635SUPPL2012-08-14
21401SUPPL2012-08-14
26609SUPPL2011-10-26
14266SUPPL2011-10-25
14265SUPPL2008-06-05
4185SUPPL2008-05-14
4184SUPPL2007-10-15
14264SUPPL2007-10-10
14263SUPPL2007-10-04
4183SUPPL2004-06-02
23621ORIG2003-11-20
4182SUPPL2002-07-08
26608SUPPL2002-02-21
41917ORIG2001-07-31
26607ORIG2001-07-31
14262ORIG2001-07-31